|4Oct 1, 5:14 PM ET

Marshall Dennis E 4

4 · BIOLARGO, INC. · Filed Oct 1, 2024

Insider Transaction Report

Form 4
Period: 2024-09-29
Transactions
  • Award

    Option to Purchase Common Stock

    2024-09-29+93,7494,390,283 total
    Exercise: $0.24From: 2024-09-29Exp: 2034-09-29Common Stock (93,749 underlying)
  • Award

    Option to Purchase Common Stock

    2024-09-30+81,5224,471,805 total
    Exercise: $0.23From: 2024-09-30Exp: 2034-09-30Common Stock (81,522 underlying)
Footnotes (3)
  • [F1]This Option was granted to Reporting Person to replace an option to purchase 47,872 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F2]Total reflects the expiration of options to purchase 47,872 shares that recently expired.
  • [F3]This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan.

Documents

2 files